Hemostats Market by Product (Thrombin, Oxidised Regenerated Cellulose, Combination, Gelatin, Collagen), Application (Gynecology, Neurology, Cardiovascular, Reconstructive), Formulation (Powder, Matrix & Gel, Sheets & Pads) - Global Forecast to 2023

The hemostats market is expected to reach USD 3.03 billion by 2023 from USD 2.14 billion in 2017 at a CAGR of 6.0%. The base year for this study is 2017 and the forecast period is 2018–2023.

The Objectives of this Study are as follows:

• To define, describe, and forecast the hemostats market by product, application, formulation, and region
• To forecast the revenue of the market segments with respect to four main regional segments, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
• To identify micromarkets and the drivers, opportunities, and trends affecting the growth of the market
• To strategically analyze market segments and subsegments with respect to individual growth trends, prospects, and contributions to the overall market
• To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
• To profile key players and comprehensively analyze their market shares and core competencies in terms of market developments and growth strategies
• To track and analyze competitive developments such as collaborations, acquisitions, product launches, expansions, and R&D activities in the hemostats market

Research Methodology

Top-down and bottom-up approaches were used to estimate and validate the size of the market and the size of various other dependent submarkets. The overall market size was used in the top-down approach to estimate the sizes of other individual submarkets (mentioned in the market segmentation—by product, formulation, and application) through percentage splits from secondary and primary research. The bottom-up approach was also implemented (wherever applicable) for data extracted from secondary research to validate the market segment revenues obtained.

Various secondary sources such as International Society on Thrombosis and Haemostasis (ISTH), Thrombosis and Hemostasis Societies of North America (THSNA), American Association for the Surgery of Trauma (AAST), Asian-Pacific Society on Thrombosis and Hemostasis (APSTH), Thrombosis and Haemostasis Society of Australia and New Zealand (THANZ), European Thrombosis & Haemostasis Alliance (ETHA), World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), and PubMed have been used to identify and collect information useful for this extensive commercial study of the hemostats market. Primary sources such as experts from related industries and suppliers have been interviewed to obtain and verify critical information as well as to assess the prospects of the hemostats market. The breakdown of profiles of primaries is shown in the figure below:

To know about the assumptions considered for the study, download the pdf brochure

The major players in the hemostats market include CR Bard, Inc. (US). B. Braun Melsungen AG (Germany), Baxter International, Inc. (US), Integra LifeSciences (US), Marine Polymer Technologies, Inc. (US), Teleflex (US), Ethicon, Inc. (US), Pfizer, Inc. (US), Z-Medica LLC (US), and Gelita Medical GmbH (Germany).

Target Audience for this Report:

• Manufacturers and vendors of hemostats products
• Distributors of hemostats products
• Venture capitalists
• Various research and consulting firms
• Hospitals and clinics
• Ambulatory surgical centers
• Medical device companies

Scope of the Report:

This report categorizes the hemostats market into the following segments:

By Product

• Thrombin-based hemostats
• Oxidized regenerated cellulose based hemostats
• Combination hemostats
• Gelatin-based hemostats
• Collagen-based hemostats

By Application

• Orthopedic surgery
• General surgery
• Neurological surgery
• Cardiovascular surgery
• Reconstructive surgery
• Gynecological surgery
• Other surgeries

By Formulation

• Matrix & gel hemostats
• Sheet & pad hemostats
• Sponge hemostats
• Powder hemostats

By Region

• North America
  • US
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Russia
  • Switzerland
  • Belgium
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • Singapore
  • New Zealand
  • South Korea
  • Indonesia
  • Malaysia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East and Africa

Customization Options:

• Company Information: Detailed company profiles of five or more market players
• Opportunity Assessment: A detailed report underlining the various growth opportunities presented in the market

Table of Contents

1 Introduction (Page No. - 14)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Market Covered
    1.4 Years Considered for the Study
    1.5 Currency
    1.6 Limitations
    1.7 Stakeholders

2 Research Methodology (Page No. - 17)
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Key Data From Primary Sources
    2.2 Market Size Estimation
           2.2.1 Bottom-Up Approach
           2.2.2 Top-Down Approach
    2.3 Data Triangulation Methodology
    2.4 Assumptions for the Study

3 Executive Summary (Page No. - 24)

4 Premium Insights (Page No. - 27)
    4.1 Hemostats: Market Overview
    4.2 Asia Pacific: Hemostats Market, By Formulation (2018)
    4.3 Hemostats Market, By Region (2018)
    4.4 Geographical Snapshot of the Hemostats Market

5 Market Overview (Page No. - 31)
    5.1 Introduction
    5.2 Market Dynamics
    5.3 Drivers
           5.3.1 Increasing Number of Surgical Procedures
           5.3.2 Growing Number of Regulatory Approvals
           5.3.3 Increasing Incidence of Sports-Related Injuries and Spinal Ailments
           5.3.4 Rising Focus on Effective Blood Loss Management in Patients During Surgeries
    5.4 Market Opportunities
           5.4.1 Growth in the Number of Hospitals & Surgical Centers
           5.4.2 Emerging Markets
    5.5 Market Restraints
           5.5.1 Product Recalls
           5.5.2 Highly Consolidated Market
    5.6 Market Challenges
           5.6.1 Dearth of Skilled Personnel
           5.6.2 High Cost of Hemostats

6 Hemostats Market, By Product (Page No. - 37)
    6.1 Introduction
    6.2 Thrombin-Based Hemostats
    6.3 Oxidized Regenerated Cellulose-Based Hemostats
    6.4 Combination Hemostats
    6.5 Gelatin-Based Hemostats
    6.6 Collagen-Based Hemostats

7 Hemostats Market, By Formulation (Page No. - 45)
    7.1 Introduction
    7.2 Matrix & Gel Hemostats
    7.3 Sheet & Pad Hemostats
    7.4 Sponge Hemostats
    7.5 Powder Hemostats

8 Hemostats Market, By Application (Page No. - 51)
    8.1 Introduction
    8.2 Orthopedic Surgery
    8.3 General Surgery
    8.4 Neurological Surgery
    8.5 Cardiovascular Surgery
    8.6 Reconstructive Surgery
    8.7 Gynecological Surgery
    8.8 Other Surgeries

9 Hemostats Market, By Region (Page No. - 61)
    9.1 Introduction
    9.2 North America
           9.2.1 US
           9.2.2 Canada
    9.3 Europe
           9.3.1 Germany
           9.3.2 UK
           9.3.3 France
           9.3.4 Italy
           9.3.5 Spain
           9.3.6 Russia
           9.3.7 Switzerland
           9.3.8 Belgium
           9.3.9 Rest of Europe
    9.4 Asia Pacific
           9.4.1 China
           9.4.2 Japan
           9.4.3 India
           9.4.4 Australia
           9.4.5 Singapore
           9.4.6 New Zealand
           9.4.7 South Korea
           9.4.8 Indonesia
           9.4.9 Malaysia
           9.4.10 Rest of Asia Pacific
    9.5 Latin America
           9.5.1 Brazil
           9.5.2 Mexico
           9.5.3 Rest of Latin America
    9.6 Middle East and Africa

10 Competitive Landscape (Page No. - 110)
     10.1 Overview
     10.2 Market Share Analysis
     10.3 Competitive Scenario
             10.3.1 Product Launches and Approvals
             10.3.2 Acquisitions
             10.3.3 Agreements
             10.3.4 Expansions

11 Company Profiles (Page No. - 114)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
     11.1 C. R. Bard
     11.2 B.Braun
     11.3 Baxter
     11.4 Integra Lifesciences
     11.5 Marine Polymer Technologies
     11.6 Pfizer
     11.7 Gelita Medical GmbH
     11.8 Z-Medica, LLC
     11.9 Ethicon (Subsidiary of Johnson & Johnson)
     11.10 Teleflex Incorporated

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. - 132)
     12.1 Insights of Industry Experts
     12.2 Discussion Guide
     12.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     12.4 Available Customizations
     12.5 Related Reports
     12.6 Author Details

List of Tables (101 Tables)

Table 1 Hemostats Market, By Product, 2016–2023 (USD Million)
Table 2 Hemostats Market, By Product, 2016–2023 (Thousand Units)
Table 3 Thrombin-Based Hemostats Market, By Region, 2016–2023 (USD Million)
Table 4 Thrombin-Based Hemostats Market, By Region, 2016–2023 (Thousand Units)
Table 5 Oxidized Regenerated Cellulose-Based Hemostats Market, By Region, 2016–2023 (USD Million)
Table 6 Oxidized Regenerated Cellulose-Based Hemostats Market, By Region, 2016–2023 (Thousand Units)
Table 7 Combination Hemostats Market, By Region, 2016–2023 (USD Million)
Table 8 Combination Hemostats Market, By Region, 2016–2023 (Thousand Units)
Table 9 Gelatin-Based Hemostats Market, By Region, 2016–2023 (USD Million)
Table 10 Gelatin-Based Hemostats Market, By Region, 2016–2023 (Thousand Units)
Table 11 Collagen-Based Hemostats Market, By Region, 2016–2023 (USD Million)
Table 12 Collagen-Based Hemostats Market, By Region, 2016–2023 (Thousand Units)
Table 13 Hemostats Market, By Formulation, 2016–2023 (USD Million)
Table 14 Matrix & Gel Hemostats Market, By Region, 2016–2023 (USD Million)
Table 15 Sheet & Pad Hemostats Market, By Region, 2016–2023 (USD Million)
Table 16 Sponge Hemostats Market, By Region, 2016–2023 (USD Million)
Table 17 Powder Hemostats Market, By Region, 2016–2023 (USD Million)
Table 18 Hemostats Market, By Application, 2016–2023 (USD Million)
Table 19 Hemostats Market for Orthopedic Surgery, By Region, 2016–2023 (USD Million)
Table 20 Hemostats Market for General Surgery, By Region, 2016–2023 (USD Million)
Table 21 Hemostats Market for Neurological Surgery, By Region, 2016–2023 (USD Million)
Table 22 Hemostats Market for Cardiovascular Surgery, By Region, 2016–2023 (USD Million)
Table 23 Hemostats Market for Reconstructive Surgery, By Region, 2016–2023 (USD Million)
Table 24 Countries With the Highest C-Section Rate (2015)
Table 25 Hemostats Market for Gynecological Surgery, By Region, 2016–2023 (USD Million)
Table 26 Hemostats Market for Other Surgeries, By Region, 2016–2023 (USD Million)
Table 27 Hemostats Market, By Region, 2016–2023 (USD Million)
Table 28 North America: Hemostats Market, By Country, 2016–2023 (USD Million)
Table 29 North America: Hemostats Market, By Product, 2016–2023 (USD Million)
Table 30 North America: Hemostats Market, By Product, 2016-2023 (Thousand Units)
Table 31 North America: Hemostats Market, By Formulation, 2016–2023 (USD Million)
Table 32 North America: Hemostats Market, By Application, 2016–2023 (USD Million)
Table 33 US: Hemostats Market, By Product, 2016–2023 (USD Million)
Table 34 US: Hemostats Market, By Product, 2016–2023 (Thousand Units)
Table 35 Canada: Hemostats Market, By Product, 2016–2023 (USD Million)
Table 36 Canada: Hemostats Market, By Product, 2016–2023 (Thousand Units)
Table 37 Europe: Hemostats Market, By Country, 2016–2023 (USD Million)
Table 38 Europe: Hemostats Market, By Product, 2016–2023 (USD Million)
Table 39 Europe: Hemostats Market, By Product, 2016–2023 (Thousand Units)
Table 40 Europe: Hemostats Market, By Formulation, 2016–2023 (USD Million)
Table 41 Europe: Hemostats Market, By Application, 2016–2023 (USD Million)
Table 42 Germany: Hemostats Market, By Product, 2016–2023 (USD Million)
Table 43 Germany: Hemostats Market, By Product, 2016–2023 ( Thousand Units)
Table 44 UK: Hemostats Market, By Product, 2016–2023 (USD Million)
Table 45 UK: Hemostats Market, By Product, 2016–2023 (Thousand Units)
Table 46 France: Hemostats Market, By Product, 2016–2023 (USD Million)
Table 47 France: Hemostats Market, By Product, 2016–2023 (Thousand Units)
Table 48 Italy: Hemostats Market, By Product, 2016–2023 (USD Million)
Table 49 Italy: Hemostats Market, By Product, 2016–2023 (Thousand Units)
Table 50 Spain: Hemostats Market, By Product, 2016–2023 (USD Million)
Table 51 Spain: Hemostats Market, By Product, 2016–2023 (Thousand Units)
Table 52 Russia: Hemostats Market, By Product, 2016–2023 (USD Million)
Table 53 Russia: Hemostats Market, By Product, 2016–2023 (Thousand Units)
Table 54 Switzerland: Hemostats Market, By Product, 2016–2023 (USD Million)
Table 55 Switzerland: Hemostats Market, By Product, 2016–2023 (Thousand Units)
Table 56 Belgium: Hemostats Market, By Product, 2016–2023 (USD Million)
Table 57 Belgium: Hemostats Market, By Product, 2016–2023 (Thousand Units)
Table 58 RoE: Hemostats Market, By Product, 2016–2023 (USD Million)
Table 59 RoE: Hemostats Market, By Product, 2016–2023 (Thousand Units)
Table 60 Asia Pacific: Hemostats Market, By Country, 2016–2023 (USD Million)
Table 61 Asia Pacific: Hemostats Market, By Product, 2016–2023 (USD Million)
Table 62 Asia Pacific: Hemostats Market, By Product, 2016–2023 (Thousand Units)
Table 63 Asia Pacific: Hemostats Market, By Formulation, 2016–2023 (USD Million)
Table 64 Asia Pacific: Hemostats Market, By Application, 2016–2023 (USD Million)
Table 65 China: Hemostats Market, By Product, 2016–2023 (USD Million)
Table 66 China: Hemostats Market, By Product, 2016–2023 (Thousand Units)
Table 67 Japan: Hemostats Market, By Product, 2016–2023 (USD Million)
Table 68 Japan: Hemostats Market, By Product, 2016–2023 (Thousand Units)
Table 69 India: Hemostats Market, By Product, 2016–2023 (USD Million)
Table 70 India: Hemostats Market, By Product, 2016–2023 (Thousand Units)
Table 71 Australia: Hemostats Market, By Product, 2016–2023 (USD Million)
Table 72 Australia: Hemostats Market, By Product, 2016–2023 (Thousand Units)
Table 73 Singapore: Hemostats Market, By Product, 2016–2023 (USD Million)
Table 74 Singapore: Hemostats Market, By Product, 2016–2023 (Thousand Units)
Table 75 New Zealand: Hemostats Market, By Product, 2016–2023 (USD Million)
Table 76 New Zealand: Hemostats Market, By Product, 2016–2023 (Thousand Units)
Table 77 South Korea: Hemostats Market, By Product, 2016–2023 (USD Million)
Table 78 South Korea: Hemostats Market, By Product, 2016–2023 (Thousand Units)
Table 79 Indonesia: Hemostats Market, By Product, 2016–2023 (USD Million)
Table 80 Indonesia: Hemostats Market, By Product, 2016–2023 (Thousand Units)
Table 81 Malaysia: Hemostats Market, By Product, 2016–2023 (USD Million)
Table 82 Malaysia: Hemostats Market, By Product, 2016–2023 (Thousand Units)
Table 83 RoAPAC: Hemostats Market, By Product, 2016–2023 (USD Million)
Table 84 RoAPAC: Hemostats Market, By Product, 2016–2023 (Thousand Units)
Table 85 Latin America: Hemostats Market, By Country, 2016–2023 (USD Million)
Table 86 Latin America: Hemostats Market, By Product, 2016–2023 (USD Million)
Table 87 Latin America: Hemostats Market, By Product, 2016–2023 (Thousand Units)
Table 88 Latin America: Hemostats Market, By Formulation, 2016–2023 (USD Million)
Table 89 Latin America: Hemostats Market, By Application, 2016–2023 (USD Million)
Table 90 Brazil: Key Macroindicators for the Hemostats Market
Table 91 Brazil: Hemostats Market, By Product, 2016–2023 (USD Million)
Table 92 Brazil: Hemostats Market, By Product, 2016–2023 (Thousand Units)
Table 93 Mexico: Hemostats Market, By Product, 2016–2023 (USD Million)
Table 94 Mexico: Hemostats Market, By Product, 2016–2023 (Thousand Units)
Table 95 Rest of Latin America: Hemostats Market, By Product, 2016–2023 (USD Million)
Table 96 Rest of Latin America: Hemostats Market, By Product, 2016–2023 (Thousand Units)
Table 97 Middle East and Africa: Hemostats Market, By Country, 2016–2023 (USD Million)
Table 98 Middle East and Africa: Hemostats Market, By Product, 2016–2023 (USD Million)
Table 99 Middle East and Africa: Hemostats Market, By Product, 2016–2023 (Thousand Units)
Table 100 Middle East and Africa: Hemostats Market, By Formulation, 2016–2023 (USD Million)
Table 101 Middle East and Africa: Hemostats Market, By Application, 2016–2023 (USD Million)

List of Figures (28 Figures)

Figure 1 Research Methodology
Figure 2 Breakdown of Primary Interviews
Figure 3 Bottom-Up Approach
Figure 4 Top-Down Approach
Figure 5 Data Triangulation
Figure 6 Hemostats Market, By Product, 2018 vs 2023 (USD Million)
Figure 7 Hemostats Market, By Formulation, 2018 vs 2023 (USD Million)
Figure 8 Hemostats Market, By Application, 2018 vs 2023 (USD Million)
Figure 9 Hemostats Market, By Region, 2018 vs 2023 (USD Million)
Figure 10 Increasing Number of Surgical Procedures is Expected to Drive Market Growth
Figure 11 Matrix and Gel Hemostats are Expected to Command the Largest Market Share in 2018
Figure 12 North America is Expected to Hold the Largest Share of the Hemostats Market in 2018
Figure 13 India to Register the Highest CAGR During the Forecast Period
Figure 14 Hemostats Market: Drivers, Restraints, Opportunities, and Challenges
Figure 15 Combination Hemostats to Witness the Highest Growth in the Hemostats Market During the Forecast Period
Figure 16 Sponge Hemostats to Witness the Highest Growth During the Forecast Period
Figure 17 Reconstructive Surgery to Witness the Highest Growth During the Forecast Period
Figure 18 North America to Dominate the Global Hemostats Market in 2018
Figure 19 North America: Hemostats Market Snapshot
Figure 20 Key Developments of Major Players From 2015 to 2018
Figure 21 Hemostats Market Share Analysis, By Key Players, 2017
Figure 22 C. R. Bard: Company Snapshot (2016)
Figure 23 B. Braun: Company Snapshot (2017)
Figure 24 Baxter: Company Snapshot (2017)
Figure 25 Integra Lifesciences: Company Snapshot (2017)
Figure 26 Pfizer: Company Snapshot (2017)
Figure 27 Johnson & Johnson Services, Inc.: Company Snapshot (2017)
Figure 28 Teleflex Incorporated: Company Snapshot (2017)

The global hemostats market is expected to reach USD 3.03 billion by 2023 from USD 2.27 billion in 2018, at a CAGR of 6.0%. Growth in this market is driven by the increasing number of surgical procedures, growing number of regulatory approvals, increasing incidence of sports-related injuries and spinal ailments, and rising focus on effective blood loss management in patients during surgeries. In addition, the emerging markets and growth in the number of hospitals and surgical centers are expected to offer further growth opportunities for players operating in the hemostats market during the forecast period.

The global hemostats market is segmented by product, application, formulation, and region.

Based on applications, the hemostats market is segmented into neurological surgery, cardiovascular surgery, general surgery, orthopedic surgery, thoracic surgery, gynecological surgery, urological surgery, and reconstructive surgery. The orthopedic surgery segment is expected to account for the largest share of the hemostats market in 2018. The growing geriatric population, increasing incidence of sports injuries, and the growing prevalence of lifestyle disorders (such as arthritis, osteoporosis, and obesity) are some of the major factors responsible for the growth in the number of orthopedic surgeries performed globally. The growing number of orthopedic surgeries is in turn expected to support the growth of dependent markets, such as the hemostats market for orthopedic applications.

Based on product, the hemostats market is segmented into thrombin-based hemostats, oxidized regenerated cellulose-based hemostats, combination hemostats, gelatin-based hemostats, and collagen-based hemostats. The thrombin-based hemostats segment is expected to account for the largest share of the market in 2018. The large share of this market segment can primarily be attributed to the wide range of advantages associated with the use of thrombin-based hemostats.

Based on formulation, the hemostats market is further segmented into matrix & gel hemostats, sheet & pad hemostats, sponge hemostats, and powder hemostats. In 2018, the matrix & gel hemostats segment is expected to account for the largest share of the hemostats market. The large share of this market segment can primarily be attributed to the advantages associated with the use of these formulations, such as lightweight and ease of use. Sponge hemostats, on the other hand, are expected to witness the highest growth in the market during the forecast period. Market growth can largely be attributed to the growing acceptance of these formulations by end users.

On the basis of region, the hemostats market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2018, North America is expected to account for the largest share of the global hemostats market. The hemostats market in North America is well-established, with the US being a major market in this region. Growth in the North American market is majorly driven by the growing geriatric population and increasing number of surgeries in the region.

APAC countries, particularly China and India, are expected to offer significant growth opportunities for market players in the forecast period, primarily due to improving healthcare infrastructure, growing medical tourism, and increasing number of elderly people in the region.

The major players in the hemostats market include CR Bard, Inc. (US). B. Braun Melsungen AG (Germany), Baxter International, Inc. (US), Integra LifeSciences (US), Marine Polymer Technologies, Inc. (US), Teleflex (US), Ethicon, Inc. (US), Pfizer, Inc. (US), Z-Medica LLC (US), and Gelita Medical GmbH (Germany).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst